CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

200 hedge funds and large institutions have $2.73B invested in Cymabay Therapeutics in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+11
Holders Change %
+5.82%
% of All Funds
2.93%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
46
Increased
79
Reduced
60
Closed
33
Calls
$84.7M
Puts
$20.6M
Net Calls
+$64.2M
Net Calls Change
+$62M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$105M
2
BlackRock
2
BlackRock
New York
$227M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$72.3M
4
SI
4
Sofinnova Investments
California
$33.3M
5
Morgan Stanley
5
Morgan Stanley
New York
$45.2M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$42.5M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$62.1M
3
NIP
3
Nicholas Investment Partners
California
$10.3M
4
FCMI
4
Foresite Capital Management IV
California
$0
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$144M
Name Holding Trade Value Shares
Change 		Shares
Change %
AAA
26
Affinity Asset Advisors
New York
$25.8M -$920K -38,935 -3%
Northern Trust
27
Northern Trust
Illinois
$25.7M +$1.95M +82,575 +8%
EA
28
Emerald Advisers
Pennsylvania
$25.2M +$2.01M +84,886 +9%
Millennium Management
29
Millennium Management
New York
$21.8M +$18.4M +777,926 +542%
NHAS
30
Novo Holdings A/S
Denmark
$21.3M -$15.7M -666,521 -43%
EMFAT
31
Emerald Mutual Fund Advisers Trust
Pennsylvania
$20.7M +$1.62M +68,537 +8%
Charles Schwab
32
Charles Schwab
California
$20.2M +$1.3M +54,920 +7%
DCM
33
Driehaus Capital Management
Illinois
$19.9M +$19.9M +841,677 New
Nuveen Asset Management
34
Nuveen Asset Management
Illinois
$17.8M +$1.23M +52,116 +7%
SVCM
35
Saturn V Capital Management
Texas
$17.7M -$8.84M -374,209 -33%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$17.6M +$17.6M +746,353 New
Invesco
37
Invesco
Georgia
$17.2M -$5.06M -214,102 -23%
Westfield Capital Management
38
Westfield Capital Management
Massachusetts
$16.5M +$16.5M +700,056 New
Victory Capital Management
39
Victory Capital Management
Texas
$16.3M -$8.22M -347,830 -34%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$15M -$3.81M -161,112 -20%
Goldman Sachs
41
Goldman Sachs
New York
$14.9M +$1.65M +69,974 +12%
MB
42
MPM BioImpact
Massachusetts
$14.4M +$9.71K +411 +0.1%
JFG
43
Jefferies Financial Group
New York
$13.8M +$13.8M +586,298 New
WP
44
Woodline Partners
California
$12.6M +$2.86M +121,287 +30%
HRCM
45
Hood River Capital Management
Florida
$12.3M +$162K +6,838 +1%
ACP
46
Acuta Capital Partners
California
$11.6M +$1.75M +74,155 +18%
ABG
47
Ally Bridge Group
New York
$11.6M +$11.6M +489,938 New
NIP
48
Nicholas Investment Partners
California
$10.3M -$33.2M -1,405,507 -76%
Bank of New York Mellon
49
Bank of New York Mellon
New York
$9.76M +$891K +37,730 +10%
TCM
50
Tang Capital Management
California
$8.27M +$3.54M +150,000 +75%
1
2
3 4 5